You are cordially invited to a Lunch Symposium at RCOG World Congress 2017
Title: NIPT - What's New? What's Next?
Abstract: The presentation will highlight key differentiators among the various NIPT commercial offerings, review recent updates from professional society guidelines and share insights into both available and anticipated expansions in the use of NIPT to screen for clinically relevant, highly prevalent genetic disorders.
Kimberly Martin, MD, Senior Global Medical Director, Women's Health, Natera Inc.
Kimberly Martin, MD, FRCSC, FCCMG, FACOG, FACMG is a recognized expert clinician in the field of interventional genetics with more than 20 years of prenatal diagnosis, ultrasound, and genetic counseling experience practicing in both academic and community-based health care settings. She is board certified in both Obstetrics and Gynecology and Clinical Genetics in Canada and the United States.
Artisan Lancet Genomics (ALG) combines the clinical diagnostic expertise of Lancet Laboratories with the high end genomics of the Centre for Proteomic and Genomic Research to bring NIPT to the African clinical diagnostic environment and connect patients to best clinical care.
Date: March 20, 2017
Time: 12:20 pm